Back to News List


Carrying out healthcare MR in the UK during difficult times - an update

May 1st, 2020

Feedback from the second EphMRA webinar providing an update on conducting fieldwork in major European markets, including the UK

Industry associations and agencies are collecting and sharing data on the impact of the Covid-19 pandemic upon our ability to carry out primary market research and we want to make sure that this information reaches our members.

The BHBIA has previously reported on webinars conducted earlier in April by EphMRA and Intellus Worldwide - click here to read our summary: 'Carrying out healthcare MR in the UK during difficult times'.

EphMRA conducted a second webinar on 30 April and kindly invited BHBIA members to attend once again.

Key messages from the update that are relevant for the UK:

  • HCPs remain very largely willing to participate in MR, there have been no major changes in the last 3 weeks.
  • MR can and is continuing; indeed some HCPs have more time for it as their patient loads have fallen in recent weeks.
  • It remains largely inappropriate to target centres or HCPs directly involved in managing Covid-19 or to use face to face methodologies.
  • In non-Covid-19 related fields, the focus is shifting to finding ways to resume more normal ways of working particularly in some fields such as oncology.
  • Carefully considered and considerate approaches by MR practitioners are paying off, response rates remain good.

The feedback was consistent both with the information presented in the first webinar on 8 April and across the countries (varying a little depending on the stage of the pandemic each country was in).

Thanks again to EphMRA for setting up and allowing BHBIA members to access the update webinar and to all the agencies involved.


This summary is for information purposes only. Whilst every reasonable effort is made to ensure the information is accurate, no responsibility for its accuracy or for any consequences of relying on it is assumed by the BHBIA.